Eli Lilly and Company, Anthem, Inc. and HealthCore pharma partners for a five-year, real-world evidence research collaboration intended to improve health outcomes for patients.
The companies will jointly develop and conduct research projects in health outcomes and real-world evidence in areas of mutual interest.
Each party will bring distinct and valuable contributions to the collaboration, including the U.S. provider and patient environment, research capabilities, therapeutics and methods expertise, and integrated, researchable data.
For further deal information visit Current Agreements (subscription required)
Report: Top 50 Big Biotech Partnering and M&A Deal Trends